Q2 2025 13F Holders as of 6/30/2025
-
Type / Class
-
Equity / Common Stock
-
Shares outstanding
-
38.5M
-
Number of holders
-
35
-
Total 13F shares, excl. options
-
5.15M
-
Shares change
-
-694K
-
Total reported value, excl. options
-
$1.44M
-
Value change
-
-$213K
-
Put/Call ratio
-
0
-
Number of buys
-
12
-
Number of sells
-
-15
-
Price
-
$0.28
Significant Holders of Co-Diagnostics, Inc. - Common Stock (CODX) as of Q2 2025
44 filings reported holding CODX - Co-Diagnostics, Inc. - Common Stock as of Q2 2025.
Co-Diagnostics, Inc. - Common Stock (CODX) has 35 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 5.15M shares
of 38.5M outstanding shares and own 13.37% of the company stock.
Largest 10 shareholders include VANGUARD GROUP INC (1.73M shares), Private Advisory Group LLC (1.18M shares), RENAISSANCE TECHNOLOGIES LLC (561K shares), BlackRock, Inc. (427K shares), GEODE CAPITAL MANAGEMENT, LLC (320K shares), JANE STREET GROUP, LLC (166K shares), Bank of New York Mellon Corp (137K shares), Kestra Advisory Services, LLC (129K shares), SUSQUEHANNA INTERNATIONAL GROUP, LLP (125K shares), and STATE STREET CORP (101K shares).
This table shows the top 35 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.